Retraction
Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies
Paper Information
Record ID:
20170
Author(s):
Publication Date:
April 16, 2010
Retraction Date:
March 21, 2019
(6.7 years years ago)
Subjects:
Institutions:
- Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
- Sarcoma Research Center, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
- Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
- Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
- Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
Country:
🇺🇸 United StatesArticle Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1371/journal.pone.0214006Additional Notes:
see also: https://pubpeer.com/publications/B0C3E8A174168169E76500DD0F49B3
Citations (160)
160
Total Citations22
Post-Retraction(13.8%)
117
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
5
Within 1 year
13
After 2+ years
2032
Days since retraction (latest)
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Unknown
Molecular insights into withaferin A: A holistic approach to cancer therapy
Md. Rezaul Islam, Abdur Rauf, M. Meenakshi Rakesh et al. (13 authors)
Inorganic Chemistry Communications
Published: Oct 2024
2032 days after retraction
The Potential Pharmacological Effects of Natural Product Withaferin A in Cancer: Opportunities and Challenges for Clinical Translation
Geetanjali Devabattula, Biswajit Panda, Rachana Yadav et al. (4 authors)
Planta Medica
Open Access
Published: Apr 2024
3 citations
3 citations
1845 days after retraction
An Overview of Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Canine Tumors: How Far Have We Come?
Federico Armando, Federico Mazzola, Luca Ferrari et al. (4 authors)
Veterinary Sciences
Open Access
Published: Dec 2022
5 citations
5 citations
1378 days after retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Dec 2022
1371 days after retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Aug 2022
1256 days after retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Jun 2022
1168 days after retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: May 2022
1153 days after retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Mar 2022
1076 days after retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Dec 2021
1005 days after retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: May 2021
793 days after retraction
Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds
Abedul Haque, Daniel A. Brazeau, A.R.M. Ruhul Amin
European Journal of Cancer
Open Access
Published: Apr 2021
97 citations
97 citations
756 days after retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Apr 2021
755 days after retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Mar 2021
737 days after retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Oct 2020
560 days after retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Sep 2020
530 days after retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: May 2020
411 days after retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Apr 2020
379 days after retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Jan 2020
303 days after retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Jul 2019
122 days after retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Jul 2019
102 days after retraction
<i>Retracted</i>: Long noncoding RNA MEG3 is a tumor suppressor in choriocarcinoma by upregulation of microRNA‐211
Ji Li, Xue Li
Journal of Cellular Physiology
Open Access
Published: May 2019
18 citations
18 citations
63 days after retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: May 2019
41 days after retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Mar 2019
Same day as retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Dec 2018
110 days before retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Nov 2018
126 days before retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Sep 2018
181 days before retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Aug 2018
230 days before retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Aug 2018
232 days before retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: Jul 2018
245 days before retraction
Paper citing Vimentin Is a Novel Anti-Cancer Therapeutic Target...
Unknown Authors
Unknown Journal
Published: May 2018
294 days before retraction
Quick Stats
Total Citations:
160
Years Since Retraction:
6.7 years
Open Access:
Yes
Last Checked:
Never